Back to Search

NICHOLAOS BELLOS, MD

MD

Internal Medicine Physician

NPI: 1962471128IndividualAccepts Medicare

Specialties, Licenses & Credentials

Infectious Disease Physician

Internal Medicine — Infectious Disease

Code: 207RI0200X

G2108(TX)
Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

G2108(TX)

CMS Specialties

PrimaryINFECTIOUS DISEASE

Additional

INTERNAL MEDICINE

Education

BAYLOR COLLEGE OF MEDICINE

Class of 1981

Research & Publications (13)

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
PMID 19542866·AIDS·2009
4-observational
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
PMID 18832245·N Engl J Med·2008
8-other
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America.
PMID 18670229·AIDS·2008
3-trial
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.
PMID 18540803·J Infect Dis·2008
2-rct
Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function.
PMID 18091608·J Acquir Immune Defic Syndr·2008
3-trial
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.
PMID 17416261·Lancet·2007
4-observational
T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen.
PMID 15747252·J Infect Dis·2005
3-trial
Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation.
PMID 15577413·J Acquir Immune Defic Syndr·2004
3-trial
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients.
PMID 15238771·AIDS·2004
3-trial
Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial.
PMID 14620390·Pharmacotherapy·2003
3-trial
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.
PMID 12965939·Ann Intern Med·2003
3-trial
Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
PMID 11797183·Clin Infect Dis·2002
3-trial
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
PMID 10983647·AIDS·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2603 OAK LAWN AVE, SUITE 500
DALLAS, TX 75219

Location

Practice Location

2603 OAK LAWN AVE, DALLAS, TX
(214) 396-4201

Quick Facts

NPI
1962471128
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
45
Publications
13

Are you this provider?

Claim Your Profile